Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3
Closed -$838 79
2025
Q2
$838 Buy
+3
New +$850 ﹤0.01% 357
2023
Q2
Sell
-244
Closed -$337K 115
2023
Q1
$337K Sell
244
-1,041
-81% -$256K 0.07% 86
2022
Q4
$337K Sell
1,285
-20
-2% -$5.36K 0.05% 89
2022
Q3
$294K Buy
1,305
+62
+5% +$15K 0.1% 97
2022
Q2
$302K Sell
1,243
-190
-13% -$46.6K 0.09% 99
2022
Q1
$347K Sell
1,433
-4,824
-77% -$1.11M 0.1% 100
2021
Q4
$1.41M Buy
6,257
+332
+6% +$70.1K 0.42% 48
2021
Q3
$1.26M Buy
5,925
+289
+5% +$66.5K 0.4% 44
2021
Q2
$1.37M Buy
5,636
+452
+9% +$111K 0.41% 41
2021
Q1
$1.29M Buy
5,184
+1,352
+35% +$323K 0.45% 38
2020
Q4
$881K Buy
3,832
+790
+26% +$182K 0.28% 50
2020
Q3
$773K Buy
3,042
+553
+22% +$137K 0.3% 50
2020
Q2
$587K Buy
+2,489
New +$568K 0.25% 55

Other funds holding AMGN

GFG Capital's AMGN Position: Q3 2025 in Review

GFG Capital sold out of Amgen (AMGN) in Q3 2025, closing a stake of 3 shares — an estimated $838 sold.

GFG Capital first reported a position in AMGN in Q2 2020 and held it in 13 quarters. The position peaked at $1.41M in Q4 2021. 2,819 funds tracked by Wall St. Rank hold AMGN as of Q3 2025.

  • GFG Capital reported no remaining Amgen position as of Q3 2025 after selling out during the quarter.
  • GFG Capital sold 3 Amgen shares in Q3 2025, an estimated $838.
  • GFG Capital first reported a position in Amgen in Q2 2020 and held it in 13 quarters.
  • GFG Capital's Amgen position peaked at $1.41M in Q4 2021.
  • 2,819 funds tracked by Wall St. Rank held Amgen as of Q3 2025.

Based on GFG Capital's 13F filing for Q3 2025, filed 7 Oct 2025.